Maximilian Gysan

Dr. Maximilian Gysan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMaximilian Gysan
Maximilian Gysan
CMChristopher Milacek
Christopher Milacek
CBChristina Bal
Christina Bal
AZAndreas Zech
Andreas Zech
JBJonas Brugger
Jonas Brugger
DGDaniela Gompelmann
Daniela Gompelmann
Several studies have shown that SARS-CoV-2 can induce a massive release of cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in the serum may help to predict disease severity and survival in COVID-19 patients. In this prospective trial, 88 patients who were hospitalised for COVID-19 were enrolled. Blood samples for serum peptide measurements were taken at the time closest to hospitalisation, at day 5, 9 and 13 (±1). The concentrations of cytokines (IL-1α, IL-1β, IL-1RA, IL-6, L-7, L-10, IFN-γ and TNF-α), chemokines (CCL-3, CCL-4 and CCL-7) and growth factors (G-CSF, GM-CSF and VEGF) were assessed and correlated with the type of ventilation, occurrence of consolidations on imaging and the level of care. COVID-19 patients (median age 68 years, IQR 55–77) stayed in hospital between 5–171 days. Compared to patients in the general care unit, patients in the intermediate care unit (IMCU) and intensive care unit (ICU) presented significantly elevated serum IL-6 (p = 0.004) and lower IFN-γ levels (p = 0.005), respectively. The peak inspiratory pressure in ventilated patients correlated positively with IL-1RA, G-CSF and inversely with IFN-γ serum levels (all p<0.05). VEGF serum levels inversely correlated with the fraction of inspired oxygen in patients receiving high-flow nasal canula oxygen therapy (p = 0.047). No significant correlation between serum concentrations of the measured peptides and the type of ventilation, occurrence of radiological consolidations or in-hospital mortality has been observed. IL1-RA, IL-6, IFN-γ, G-CSF, CCL-7 and VEGF serum levels could prove helpful as biomarkers to assess disease severity and the need for intensive care in COVID-19 patients.

22 April 2025 in Wiener klinische Wochenschrift
Verified
Journal Article
Open access
PDF file
MGMaximilian Gysan
Maximilian Gysan
ALAntje Lehmann
Antje Lehmann
DBDominik Bernitzky
Dominik Bernitzky
AZAndreas Zech
Andreas Zech
JBJonas Brugger
Jonas Brugger
DGDaniela Gompelmann
Daniela Gompelmann
Summary: Objective: Following recovery from COVID-19, there is evidence for pulmonary sequelae and functional impairment. Data regarding the immunopathological mechanisms are limited. This study aimed to investigate the relationship between bronchoalveolar lavage fluid (BALF) cellularity, lung function impairment and high-resolution computed tomography (HRCT) changes in post-COVID syndrome patients. Methods: Patients with post-COVID syndrome were enrolled in this Austrian single-center prospective observational cohort study. All patients underwent a pulmonary function test (PFT) and chest HRCT. Those with pathological HRCT findings underwent bronchoscopy with BALF sampling for differential cell count and fluorescence-activated cell sorting analysis. Results: In this study 26 patients with post-COVID syndrome underwent bronchoscopy with BAL. The HRCT showed ground-glass opacifications (69.2%), organizing pneumonia (7.7%) or both (11.5%). The PFT revealed restrictive lung disease in 38.5% and reduced diffusion capacity in 68%, 19.2% showed a pathological BAL cell pattern predominantly consisting of CD4 + T‑cells. The BALF lymphocyte count was associated with reduced forced vital capacity ( p = 0.016) and an elevated alveolar-arterial oxygen gradient ( p = 0.04). Conclusion: A notable percentage of patients with post-COVID syndrome with persistent HRCT changes showed T‑helper lymphocytic inflammation in the lungs. The degree of alveolar lymphocytosis was associated with lung function impairment. This could suggest that a prolonged inflammatory response in the alveolar compartment contributes to the pathogenesis of post-COVID syndrome.

Verified
Journal Article
Open access
PDF file
MGMaximilian Gysan
Maximilian Gysan
KKKastriot Kastrati
Kastriot Kastrati
SPSvitlana Pochepnia
Svitlana Pochepnia
HPHelmut Prosch
Helmut Prosch
LLLehmann Lehmann
Lehmann Lehmann
HRHelga Radner
Helga Radner
Background: Systemic autoimmune rheumatic diseases-associated interstitial lung disease (SARD-ILD) presents with varied disease courses, emphasizing the need for reliable predictors of progression. The prognostic utility of bronchoalveolar lavage (BAL) in SARD-ILD remains underexplored. The objective of this study was to evaluate the role of BAL fluid lymphocyte count in predicting disease progression in patients with SARD-ILD. Methods: This observational study included patients with SARD-ILD undergoing BAL as part of their diagnostic workup. Disease progression was defined as either Forced vital capacity (FVC) decrease >10%, two out of the following three criteria within two years: FVC decrease of 5–10%, worsening symptoms, increased fibrosis on imaging, or any of the following: escalation of treatment, Interstitial lung disease (ILD) exacerbation, lung transplantation, or disease-specific mortality. Logistic regression identified predictors of progression. Time-to-progression was assessed using Kaplan–Meier survival curves. The optimal BAL lymphocyte threshold for predicting progression was identified using the Youden Index and the Wilcoxon method. Results: We identified 89 patients, of whom 30 (33.7%) had progressive disease. Progressors had a significantly higher BAL lymphocyte count compared to non-progressors (31.6 ± 24.8% vs. 14.3 ± 16.5%, p < 0.001). BAL lymphocyte proportion was significantly and independently associated with disease progression (odds ratio, 1.05; 95% confidence interval 1.02–1.07; p < 0.01). A lymphocyte count above 9 percent was associated with a markedly increased risk of disease progression (odds ratio, 13.14; 95% confidence interval, 4.20–51.98; p < 0.01). Conclusions: BAL lymphocyte count was associated with a higher likelihood of progression in SARD-ILD. BAL assessment may help identify patients at increased risk of disease progression. However, these findings should be considered exploratory and require validation in larger prospective studies and across individual SARD-ILD subtypes.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
MGMaximilian Gysan
Maximilian Gysan
SSSeyer Safi
Seyer Safi
DWDorothea Weber
Dorothea Weber
RBRouven Behnisch
Rouven Behnisch
TMThomas Muley
Thomas Muley
MEMartin Eichhorn
Martin Eichhorn
Background: Recent data of operative outcomes following surgery with curative intent for non-small cell lung cancer (NSCLC) suggest that morbidity and mortality are comparable amongst different age groups. Methods: We identified 2015 patients with postoperative stage IA to IIIA NSCLC who had undergone surgery with curative intent at a single specialized lung cancer center from January 2010 to December 2015. We assessed short-term operative outcomes as postoperative morbidity, length of hospital stay, 90-day mortality and long-term operative outcomes in a matched-pair cohort (n=454) including 227 elderly patients (≥ 75 years) and corresponding 227 younger patients. Results: The rate of postoperative complications was comparable amongst the age groups (42% in the elderly vs. 36%, p=0.163), as were the median length of hospital stay (14 days in elderly vs. 13 days, p=0.185) and the 90-day mortality (4% in the elderly vs. 2.2%, p=0.424). In the elderly ECOG ≥ 1 was associated with decreased overall survival (HR=2.15, CI 1.34-3.46), as were preoperative serum C-reactive protein / albumin ratio ≥ 0.3 (HR=1.95, CI 1.23-3.11) and elevated preoperative serum creatinine levels ≥ 1.1 mg/dl (HR=1.84, CI 1.15-2.95). In the younger cohort male sex (HR=2.26, CI 1.17-4.36), postoperative stage III disease (HR 4.61, CI 2.23-9.54) and preoperative anemia (HR 2.09, CI 1.10-3.96) were associated with decreased overall survival. Conclusions: Our data suggest that preoperative treatment decision-making in the elderly should primarily consider individual assessment of patients’ functional performance. Advanced age alone should not exclude patients from surgery for resectable NSCLC.